Skip to main content
TipRanks
Go Ultimate75% OFF

Nascent Pharma Holdings (NASC) Revenue

28 Followers

Nascent Pharma Holdings Revenue

Nascent Pharma Holdings had a revenue of 15.27K in the quarter ending Sep 30, 2024, with -94.39%. This bring the company's revenue in the last twelve months to 1.03M, Decreased 28.09%. In the fiscal year ending Dec 31, 2024, Nascent Pharma Holdings had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)
1.03M
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
12
Market Cap
$1.39M

Revenue Chart

Nascent Pharma Holdings Revenue - Annual

02M4M6M8M122.75K668.60K2.31M1.71M4.60M6.69M2.16M20172018202020212021202220232024
Revenue History
Download to Excel
NASC revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20240.00-2.16M-100.00%
Dec 31, 20232.16M-4.53M-67.76%
Dec 31, 20226.69M2.08M45.22%
Dec 31, 20214.60M2.89M169.28%
Mar 31, 20211.71M-595.83K-25.84%
Mar 31, 20202.31M1.64M244.82%
Dec 31, 2018668.60K545.86K444.70%
Dec 31, 2017122.75K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
NASC1.03M
CPHI3.91M
RDHL0.00
PRFX39.50K
UPC17.74M
SHPH0.00